Related references
Note: Only part of the references are listed.Response to: Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: High-field iMRI versus conventional and 5-ALA-assisted surgery
P. Schucht et al.
EJSO (2015)
5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma
Philippe Schucht et al.
ACTA NEUROCHIRURGICA (2014)
Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: High-field iMRI versus conventional and 5-ALA-assisted surgery
C. Roder et al.
EJSO (2014)
Maximum Safe Resection of Glioblastoma Multiforme
Michel Lacroix et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Extent of Resection of Glioblastoma Revisited: Personalized Survival Modeling Facilitates More Accurate Survival Prediction and Supports a Maximum-Safe-Resection Approach to Surgery
Nicholas F. Marko et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma
Kaisorn L. Chaichana et al.
NEURO-ONCOLOGY (2014)
Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment
Jan Coburger et al.
NEUROSURGICAL FOCUS (2014)
A new philosophy in surgery for diffuse low-grade glioma (DLGG): Oncological and functional outcomes
H. Duffau
NEUROCHIRURGIE (2013)
Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis
Vibeke A. Larsen et al.
NEURORADIOLOGY (2013)
Quantitative volumetric analysis of gliomas with sequential MRI and 11C-methionine PET assessment: patterns of integration in therapy planning
Javier Arbizu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Optimizing the extent of resection in eloquently located gliomas by combining intraoperative MRI guidance with intraoperative neurophysiological monitoring
Christian Senft et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging
Ramon F. Barajas et al.
NEURO-ONCOLOGY (2012)
Gross Total Resection Rates in Contemporary Glioblastoma Surgery: Results of an Institutional Protocol Combining 5-Aminolevulinic Acid Intraoperative Fluorescence Imaging and Brain Mapping
Philippe Schucht et al.
NEUROSURGERY (2012)
Improving the Extent of Malignant Glioma Resection by Dual Intraoperative Visualization Approach
Ilker Y. Eyuepoglu et al.
PLOS ONE (2012)
Comparison of 18F-FET PET and 5-ALA fluorescence in cerebral gliomas
Frank Willi Floeth et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study Clinical article
Walter Stummer et al.
JOURNAL OF NEUROSURGERY (2011)
An extent of resection threshold for newly diagnosed glioblastomas
Nader Sanai et al.
JOURNAL OF NEUROSURGERY (2011)
Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial
Christian Senft et al.
LANCET ONCOLOGY (2011)
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
M. J. van den Bent et al.
LANCET ONCOLOGY (2011)
Quantification of Glioma Removal by Intraoperative High-Field Magnetic Resonance Imaging: An Update
Daniela Kuhnt et al.
NEUROSURGERY (2011)
Impact of the Combination of 5-Aminolevulinic Acid-Induced Fluorescence with Intraoperative Magnetic Resonance Imaging-Guided Surgery for Glioma
Atsushi Tsugu et al.
WORLD NEUROSURGERY (2011)
Morphological and flow cytometric analysis of cell infiltration in glioblastoma: a comparison of autopsy brain and neuroimaging
Takahiro Yamahara et al.
BRAIN TUMOR PATHOLOGY (2010)
5-Aminolevulinic Acid Is a Promising Marker for Detection of Anaplastic Foci in Diffusely Infiltrating Gliomas With Nonsignificant Contrast Enhancement
Georg Widhalm et al.
CANCER (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas
Florian Stockhammer et al.
ACTA NEUROCHIRURGICA (2009)
Use of dynamic susceptibility-contrast MRI (DSC-MRI) to assess perfusion changes in the ipsilateral brain parenchyma from glioblastoma
Stephan Ulmer et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
et al.
NEUROSURGERY (2009)
IMPACT OF INTRAOPERATIVE HIGH-FIELD MAGNETIC RESONANCE IMAGING GUIDANCE ON GLIOMA SURGERY: A PROSPECTIVE VOLUMETRIC ANALYSIS
Mustafa Aziz Hatiboglu et al.
NEUROSURGERY (2009)
Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience
Michael Sabel et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Glioma extent of resection and its impact on patient outcome
Nader Sanai et al.
NEUROSURGERY (2008)
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
W Stummer et al.
LANCET ONCOLOGY (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
M Lacroix et al.
JOURNAL OF NEUROSURGERY (2001)
Share Paper
